###begin article-title 0
Autocrine IGF-1 Action in Adipocytes Controls Systemic IGF-1 Concentrations and Growth
###end article-title 0
###begin p 1
###xml 40 66 40 66 <email xmlns:xlink="http://www.w3.org/1999/xlink">jens.bruening@uni-koeln.de</email>
###xml 85 113 85 113 <email xmlns:xlink="http://www.w3.org/1999/xlink">bluma@medizin.uni-leipzig.de</email>
Corresponding authors: Jens C. Bruning, jens.bruening@uni-koeln.de; Matthias Bluher, bluma@medizin.uni-leipzig.de
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-IGF-1 and the IGF-1 receptor (IGF-1R) have been implicated in the regulation of adipocyte differentiation and lipid accumulation in vitro.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1r</italic>
###xml 140 146 140 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-To investigate the role of IGF-1 receptor in vivo, we have inactivated the Igf-1r gene in adipose tissue (IGF-1RaP2Cre mice) using conditional gene targeting strategies.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 281 287 281 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
RESULTS-Conditional IGF-1R inactivation resulted in increased adipose tissue mass with a predominantly increased lipid accumulation in epigonadal fat pads. However, insulin-stimulated glucose uptake into adipocytes was unaffected by the deletion of the IGF-1R. Surprisingly, IGF-1RaP2Cre mice exhibited markedly increased somatic growth in the presence of elevated IGF-1 serum concentrations, and IGF-1 mRNA expression was significantly increased in liver and adipose tissue. IGF-1 stimulation of wild-type adipocytes significantly decreased IGF-1 mRNA expression, whereas the opposite effect was observed in IGF-1R-deficient adipocytes.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-IGF-1R signaling in adipocytes does not appear to be crucial for the development and differentiation of adipose tissue in vivo, but we identified a negative IGF-1R-mediated feedback mechanism of IGF-1 on its own gene expression in adipocytes, indicating an unexpected role for adipose tissue IGF-1 signaling in the regulation of IGF-1 serum concentrations in control of somatic growth.
###end p 6
###begin p 7
Published ahead of print at  on 28 April 2008.
###end p 7
###begin p 8
N.K. and L.K. contributed equally to this work.
###end p 8
###begin p 9
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 9
###begin p 10
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 497 503 497 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1r</italic>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 559 565 559 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1r</italic>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 919 925 919 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1r</italic>
###xml 1033 1034 1033 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1269 1270 1269 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 1432 1433 1432 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1584 1585 1578 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
###xml 815 819 <span type="species:ncbi:10090">mice</span>
###xml 1121 1125 <span type="species:ncbi:10090">Mice</span>
###xml 1578 1582 <span type="species:ncbi:10090">mice</span>
Insulin and the structurally related IGFs provide essential signals for the control of embryonic and postnatal development (1) through binding of their respective tyrosine kinase receptors. Conventional gene targeting strategies used to abrogate insulin receptor and IGF-1 receptor (IGF-1R) signaling reveal severe phenotypes of both insulin receptor-and IGF-1R-deficient mice. While inactivating the insulin receptor results in embryonic lethality (2), mice with a whole-body inactivation of the Igf-1r gene die shortly after birth (3), whereas heterozygous Igf-1r knockout mice have increased longevity, most likely due to greater resistance to oxidative stress (4). These data point to a role of IGF-1R signaling in the regulation of lifespan. To discern the relevance of IGF-1R signaling in individual tissues, mice with tissue-specific inactivation of the IGF-1R have been created. Tissue-specific knockout of the Igf-1r gene in osteoblasts displayed significant defects in bone formation with low levels of osteoblastogenesis (5), revealing a function of the IGF system in formation and maintenance of bone tissue. Mice with simultaneous functional inactivation of both insulin and IGF-1Rs in skeletal muscle have a low muscle mass and display muscle hypoplasia (6), suggesting that IGF-1 is a vital regulator of muscle development. Conversely, muscle-specific overexpression of IGF-1R resulted in local myofiber hyperplasia (7). beta-Cell-specific deletion of the IGF-1R did not alter islet development but led to hyperinsulinemia and glucose intolerance in betaIGF-1RKO mice (8). This model suggests that tissue-specific alterations in the IGF-1 signaling might have secondary effects on the organism.
###end p 10
###begin p 11
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 605 611 605 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 823 829 823 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
Until now, the role of IGF-1R signaling in white adipose tissue (WAT) has remained unclear. In 3T3-L1 adipocytes, IGF-1 is an essential regulator of differentiation (9), and it was recently shown that IGF-1 stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes in vitro (10). However, the physiological role of IGF-1R signaling in adipose tissue in vivo has not been systematically studied. To investigate the role of the IGF-1R in the development and metabolism of adipose tissue, we generated mice lacking the IGF-1R in adipose tissue (IGF-1RaP2Cre) using a conditional gene targeting approach based on the Cre recombinase. Subsequently, we characterized the consequences of IGF-1R deletion in adipose tissue on morphological and metabolic parameters of IGF-1RaP2Cre mice up to an age of 32 weeks.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin title 13
###xml 20 26 20 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Generation of IGF-1RaP2Cre mice.
###end title 13
###begin p 14
###xml 6 13 6 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox/wt</sup>
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1r</italic>
###xml 731 732 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1462 1463 1449 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1456 1463 1443 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 1532 1535 1519 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aP2</italic>
###xml 1585 1588 1572 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 1834 1836 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 77 93 <span type="species:ncbi:10678">bacteriophage P1</span>
###xml 307 313 <span type="species:ncbi:10090">murine</span>
###xml 1465 1469 <span type="species:ncbi:10090">Mice</span>
IGF-1Rflox/wt mice were created by inserting loxP [locus of crossover (x) in bacteriophage P1] sites flanking exon 3 of the Igf-1r gene using conditional gene targeting strategies and maintained on a pure C57BL/6 genetic background. A targeting vector was constructed encompassing 4.5 kb of intron 2 of the murine Igf-1r gene, a loxP site, an FRT-flanked neomycin resistance gene, 600-bp fragment containing exon 3, a second loxP site, and 1.3 kb of intron 3. Cre-mediated recombination and subsequent excision of exon 3 of the IGF-1R results in a frame shift after 213 codons, with an appended sequence of 27 amino acids followed by a stop codon in exon 4. Gene targeting was performed in Bruce4 ES cells. For transfection, 1 x 107 ES cells were transfected with 40 mug DNA. G418/Ganciclovir double-resistant colonies were picked approximately9 days after transfection and expanded on 96-well tissue culture dishes. Genomic DNA was extracted from each clone and analyzed by Southern blot and PCR analysis. Recovery, microinjection, and transfer of 3.5 day postcoitum embryos were performed according to standard procedures. Chimeric animals (80-90% chimerism based on coat color) were bred with FlpE deleter on a C57BL/6 background. Genotyping was performed by PCR on DNA extracted from tail biopsies using customized primers: 5'-TCC CTC AGG CTT CAT CCG CAA-3' (sense) and 5'-CTT CAG CTT TGC AGG TGC ACG-3' (antisense). The targeting strategy is shown in Fig. 1A. Mice on a mixed (C57BL/6 x 129/Sv) genetic background carrying the aP2 Cre transgene were made by cloning a 1.4-kb SacI/SalI complementary DNA fragment encoding the Cre recombinase, modified by inclusion of a nuclear localization sequence and a consensus polyadenylation signal, immediately downstream of the 5.4-kb promoter/enhancer of fatty acid-binding protein aP2 (11).
###end p 14
###begin p 15
###xml 6 12 6 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 44 51 44 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox/wt</sup>
###xml 68 75 68 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox/wt</sup>
###xml 169 175 169 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 410 416 402 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">AP2Cre</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
IGF-1RaP2Cre were derived by crossing IGF-1Rflox/wt mice with IGF-1Rflox/wt mice expressing the Cre recombinase under the control of the aP2 promoter/enhancer (IGF-1RhetaP2Cre). All mice were housed in pathogen-free facilities in groups of three to five at 22 +/- 2degreesC on a 12-h light/dark cycle. Animals were fed a standard chow diet (Altromin, Lage, Germany). In a subgroup of six to eight female IGF-1RAP2Cre and six wild-type mice, a high-fat diet study was performed with a special high-fat diet containing 55.2% of calories from fat (C1057; Altromin). Animals had ad libitum access to water at all times, and food was only withdrawn if required for an experiment. All experiments were performed in accordance with the rules for animal care of the local government authorities (Bezirksregierung Koln, Cologne, Germany) of the German Government and were approved by the institutional animal care and use committee.
###end p 15
###begin title 16
###xml 55 61 55 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Molecular characterization and genotyping of the IGF-1RaP2Cre mice.
###end title 16
###begin p 17
###xml 217 228 217 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1r loxP</italic>
###xml 344 347 344 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aP2</italic>
###xml 487 491 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aP2</italic>
###xml 549 553 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">loxP</italic>
###xml 577 580 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aP2</italic>
###xml 631 634 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 813 814 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 807 814 783 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 801 805 <span type="species:ncbi:10090">mice</span>
Genotyping was performed by PCR using genomic DNA isolated from the tail tip. In brief, genomic DNA was prepared by using the DNeasy kit (Qiagen, Hilden, Germany). The following two primer pairs were used to genotype Igf-1r loxP sites, 5'-TCC CTC AGG CTT CAT CCG CAA-3' (forward) and 5'-CTT CAG CTT TGC AGG TGC ACG-3' (reverse), as well as the aP2 Cre recombinase 5'-CGC CGC ATA ACC AGT GAA AC-3' (forward) and 5'-ATG TCC AAT TTA CTG ACC G-3' (reverse). PCR was performed for 25 cycles (loxP sites) or 30 cycles (aP2 Cre) of 95degreesC, 59degreesC (loxP sites), or 58degreesC (aP2 Cre), and 72degreesC (30 s each) using the Qiagen Taq Polymerase and a Peltier Thermal Cycler PTC-200 (Bio-Rad, Hercules, CA). DNA from wild-type mice produced a 300-bp band, and a 380-bp band was detected in IGF-1R lox mice (Fig. 1B). For Western blot analysis, tissues were removed and homogenized in homogenization buffer with an ultra-Turrax homogenizer (IKA Werke, Stauffen, Germany), proteins were isolated using standard techniques, and Western blot analysis was performed with antibodies raised against IGF-1R beta-subunit (Santa Cruz Biotechnology, C20) and beta-actin (Abcam, Cambridge, U.K.) as loading control.
###end p 17
###begin title 18
Phenotypic characterization.
###end title 18
###begin p 19
###xml 33 39 33 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 50 56 50 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 75 84 75 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox/flox</sup>
###xml 392 398 392 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 984 989 <span type="species:ncbi:9606">human</span>
Ten mice of each genotype (IGF-1RaP2Cre, IGF-1RhetaP2Cre, wild-type, IGF-1Rflox/flox, and aP2 Cre) of both sexes were studied from an age of 4 weeks up to 32 weeks of life. Body weight was recorded weekly up to an age of 14 weeks, and thereafter in 2-week intervals; body length (naso-anal length) was measured once at week 32. At an age of 16 weeks, both sexes of a subgroup of 20 (10 IGF-1RaP2Cre and 10 controls) underwent a food intake measurement over a time period of 1 week. The daily food intake was calculated as the average intake of chow within the time stated. Intraperitoneal glucose tolerance tests (GTTs) and insulin tolerance tests (ITTs) were performed at the age of 12 and 24 weeks. GTT was performed after an overnight fast for 16 h by injecting 2 g/kg body wt glucose and measuring the blood glucose levels after tail vein incision at 0 (baseline), 10, 30, 60, and 120 min after injection. ITT was performed in random-fed animals by injecting 0.75 unit/kg body wt human regular insulin (40 units Actrapid; Novo Nordisk, Copenhagen, Denmark). Glucose levels were determined in blood collected from the tail tip immediately before and 15, 30, and 60 min after the intraperitoneal injection.
###end p 19
###begin p 20
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed at the age of 32 weeks by an overdose of anesthetic (Sevofluran, Abbott, Germany). Liver, heart, brain, lung, spleen, subcutaneous, and epigonadal adipose tissue were immediately removed. The organs were weighed and related to the whole-body mass to obtain relative organ weights. Serum was collected at 32 weeks, and concentrations of insulin, leptin, adiponectin, and IGF-1 were measured.
###end p 20
###begin title 21
Analytical procedures.
###end title 21
###begin p 22
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
###xml 319 324 <span type="species:ncbi:10090">Mouse</span>
###xml 325 328 <span type="species:ncbi:10116">Rat</span>
###xml 369 374 <span type="species:ncbi:10090">Mouse</span>
###xml 392 397 <span type="species:ncbi:10090">Mouse</span>
Blood glucose values were determined from whole-venous blood samples using an automated glucose monitor (GlucoMen; Menarini Diagnostics, Wokingham, U.K.). Insulin, leptin, growth hormone (GH), and adiponectin serum concentrations were measured by ELISA using mouse standards according to the manufacturer's guidelines (Mouse/Rat Insulin ELISA; Linco, St. Charles, MO) (Mouse Leptin ELISA and Mouse Adiponectin/Acrp30 ELISA; R&D Systems, Minneapolis, MN). IGF-1 serum concentrations were measured by a radioimmunoassay (Mediagnost, Reutlingen, Germany).
###end p 22
###begin title 23
Adipocyte isolation, size distribution, and primary culture.
###end title 23
###begin p 24
###xml 513 514 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
Animals were killed, and subcutaneous and epididymal fat pads were removed. Adipocytes were isolated by 1 mg/ml collagenase digestion. To determine cell size distribution and adipocyte number, 200-mul aliquots of adipocytes were fixed with osmic acid, incubated for 48 h at 37degreesC, and counted in a Coulter counter (Multisizer III; Beckman Coulter, Krefeld, Germany). Isolated adipocytes were resuspended in Dulbecco's modified Eagle's medium/F-12 Ham's medium (Sigma, St. Louis, MO) and centrifuged at 350 x g for 10 min to separate mature adipocytes from the stromal vascular cell pellet, which was discarded. Floating fat-filled adipocytes were than incubated for 6 h with different concentrations (0, 0.1, 1, 10, and 100 ng/ml recombinant IGF-1 (U.S. Biological, Swampscott, MA).
###end p 24
###begin title 25
Histology.
###end title 25
###begin p 26
Tissue was fixed in 4% buffered formaldehyde, trimmed into small cubes, rinsed in phosphate-buffered saline, and dehydrated in a graded series of 50-100% ethanol followed by propylene oxide. Tissue was infiltrated with propylene:epon 812 mixtures by increasing the resin concentration gradually. Sections at 0.5 mum were cut with a Reichert ultramicrotome, mounted on polylysine-covered object slides and stained with azur-II-methylene blue (Richardson stain). Digitized pictures were taken with the light microscope Axioplan 2 (Zeiss, Jena, Germany) using the measurement facilities of Imagic Access (Imagic, Glattburg, Switzerland). Multiple sections (separated by 70-80 mum each) were obtained from gonadal and subcutaneous fat pads and analyzed systematically with respect to adipocyte size and number. For each genotype and sex, at least 10 fields (representing approximately100 adipocytes) per slide were analyzed.
###end p 26
###begin title 27
Glucose transport.
###end title 27
###begin p 28
###xml 193 195 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 383 385 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
For the determination of glucose transport, isolated adipocytes from the different fat depots were stimulated with 100 nmol/l insulin for 30 min and then incubated for 30 min with 3 mumol/l [U-14C]glucose. Immediately after incubation, adipocytes were fixed with osmic acid and incubated for 48 h at 37degreesC, and radioactivity was quantified after the cells had been decolorized (12).
###end p 28
###begin title 29
Tissue-specific IGF-1 mRNA expression.
###end title 29
###begin p 30
IGF-1 mRNA expression was measured by quantitative real-time PCR using the standard curve method in a fluorescent temperature cycler using the TaqMan assay. Fluorescence was detected on an ABI PRISM 7000 sequence detector (Applied Biosystems, Darmstadt, Germany). Total RNA was extracted from epigonadal and subcutaneous WAT, primary adipocyte culture after incubation with or without IGF-1, liver, brain, skeletal muscle, and brown adipose tissue (BAT) using TRIzol (Life Technologies, Grand Island, NY), and 1 mug RNA was reverse transcribed with standard reagents (Life Technologies, Grand Island, NY). From each RT-PCR, 2 mul was amplified in a 26-mul PCR using the Brilliant SYBR Green QPCR Core Reagent kit from Stratagene (La Jolla, CA) according to manufacturer's instructions. The following primer pairs were used: muIGF-1, 5'-GCTGCTGAAGCCATTCATTT-3' (sense) and 5'-TTGCTCTTAAGGAGGCCAAA-3' (antisense); mu36B4, 5'-aacatgctcaacatctcccc-3' (sense) and 5'-ccgactcctccgactcttc-3' (antisense). Expression of IGF-1 and 36B4 mRNA were quantified by using the second derivative maximum method of the TaqMan software (Applied Biosystems) determining the crossing points of individual samples by an algorithm that identifies the first turning point of the fluorescence curve. Amplification of specific transcripts was confirmed by melting curve profiles (cooling the sample to 68degreesC and heating slowly to 95degreesC with measurement of fluorescence) at the end of each PCR.
###end p 30
###begin title 31
Data analysis and statistics.
###end title 31
###begin p 32
###xml 122 123 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 289 290 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data are given as means +/- SD. Datasets were analyzed for statistical significance using a two-tailed unpaired Student's t test, or differences were assessed by one-way ANOVA corrected by Bonferroni-Holm using the Statistical Package for Social Science, version 14.0 (SPSS, Chicago, IL). P values <0.05 were considered significant.
###end p 32
###begin title 33
RESULTS
###end title 33
###begin title 34
###xml 20 26 20 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Generation of IGF-1RaP2Cre mice.
###end title 34
###begin p 35
###xml 49 55 49 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1r</italic>
###xml 247 250 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aP2</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 297 304 297 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 312 318 312 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 530 536 530 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 555 561 555 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 613 619 613 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1r</italic>
###xml 634 635 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 628 635 628 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 772 778 760 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 791 792 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 785 792 773 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 1035 1036 1011 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1029 1036 1005 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 1142 1151 1118 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox/flox</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 134 149 <span type="species:ncbi:10090">transgenic mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 1165 1169 <span type="species:ncbi:10090">mice</span>
Mice lacking the IGF-1R in adipose tissue (IGF-1RaP2Cre) were generated by crossing mice carrying the loxP-flanked Igf-1r allele with transgenic mice expressing the Cre recombinase under control of the adipose-specific fatty acid binding protein (aP2) promoter. The targeting strategy is shown in Fig. 1A. IGF-1RaP2Cre mice were obtained with the expected Mendelian frequency. Cre expression was expected to be restricted to WAT and BAT. PCR analysis of the genomic DNA showed that the wild-type Igf-1r allele was absent in IGF-1RaP2Cre, whereas IGF-1RhetaP2Cre mice contained both the wild-type and loxP-flanked Igf-1r allele (Fig. 1B). Western blot analysis of adipose tissue lysates clearly indicated that Igf-1r protein was reduced by approximately90% in WAT of IGF-1RaP2Cre mice (Fig. 1C) and completely lost in BAT (data not shown). A approximately40% reduction of IGF-1R protein expression was found in the brain, whereas no changes in the overall expression of the IGF-1R protein were detected in liver, skeletal muscle (Fig. 1C), kidney, and bone (data not shown). IGF-1R expression was unaffected in all tissues of wild-type, IGF-1Rflox/flox, and aP2 Cre mice, indicating that neither the loxP modification of the IGF-1R locus nor expression of the aP2 transgene alone affects IGF-1R expression. These genotypes (wild type, IGF-1Rlox/lox, and aP2 Cre) had similar physiological and metabolic characteristics and were therefore considered controls in all subsequent analyses.
###end p 35
###begin title 36
###xml 19 25 19 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Phenotype of IGF-1RaP2Cre mice.
###end title 36
###begin p 37
###xml 20 26 20 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 133 139 133 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 212 213 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 200 213 200 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic> and <italic>B</italic></xref>
###xml 246 252 246 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 357 358 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 425 426 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 419 426 419 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 460 466 460 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1r</italic>
###xml 599 605 599 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 666 672 666 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 884 885 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 878 885 866 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 901 902 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 895 902 883 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>E</italic></xref>
###xml 932 938 920 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1015 1021 1003 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1052 1053 1040 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1046 1053 1034 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>F</italic></xref>
###xml 1093 1094 1081 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1087 1094 1075 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>G</italic></xref>
###xml 1172 1178 1160 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 1179 1183 <span type="species:ncbi:10090">mice</span>
###xml 1196 1200 <span type="species:ncbi:10090">mice</span>
Both sexes of IGF-1RaP2Cre mice exhibited normal growth until the age of 10 weeks. However, by 10 weeks of age male and female IGF-1RaP2Cre mice had gained more weight than control group littermates (Fig. 2A and B). Moreover, we found that IGF-1RaP2Cre mice had significantly increased naso-anal body length when compared with littermate controls (females, P < 0.01; and males, P < 0.001) at an age of 24 and 32 weeks (Fig. 2C). Heterozygous deficiency of the Igf-1r gene had no significant influence on body growth and weight (data not shown). Daily food intake was indistinguishable between IGF-1RaP2Cre mice and all control groups (data not shown). Because IGF-1RaP2Cre mice exhibit approximately15% increased body weight, organ and fat pad weights were calculated as percentage of the whole-body weight at an age of 24 weeks. We found a disproportional increase of fat pad (Fig. 2D), liver (Fig. 2E), and heart weights in IGF-1RaP2Cre mice. In contrast, relative brain weight was significantly reduced in IGF-1RaP2Cre compared with controls (Fig. 2F). Relative organ weights of BAT (Fig. 2G), skeletal muscle, kidney, spleen, and bone were not different between IGF-1RaP2Cre mice and control mice (data not shown).
###end p 37
###begin title 38
Metabolic parameters.
###end title 38
###begin p 39
###xml 254 261 254 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 319 325 319 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 413 420 413 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 511 518 511 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 604 610 604 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 648 655 648 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 760 766 760 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 785 792 785 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 871 877 871 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 946 953 946 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 1050 1051 1050 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1056 1057 1056 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1044 1057 1044 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic> and <italic>B</italic></xref>
###xml 1093 1099 1093 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1180 1181 1180 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1186 1187 1186 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1174 1187 1174 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic> and <italic>D</italic></xref>
###xml 1259 1265 1259 1265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
###xml 1112 1116 <span type="species:ncbi:10090">mice</span>
###xml 1200 1204 <span type="species:ncbi:10090">mice</span>
###xml 1278 1282 <span type="species:ncbi:10090">mice</span>
To determine the physiological consequences of reduced adipose tissue IGF-1R expression, we monitored blood glucose, insulin, total cholesterol, and triglyceride concentrations and performed serial glucose and ITTs over an age range from 12 to 32 weeks (Table 1). Fasted blood glucose was significantly higher in IGF-1RaP2Cre mice at an age of 12 weeks, whereas no such differences were found at 24 weeks of age (Table 1). In parallel, fed blood glucose was significantly higher at an age of 12 weeks in males (Table 1). There were no differences in serum insulin and leptin concentrations between IGF-1RaP2Cre and control mice at 12 and 24 weeks (Table 1). Cholesterol and triglyceride serum concentrations were also not significantly different between IGF-1RaP2Cre and control mice (Table 1). Adiponectin serum concentrations were higher in control compared with IGF-1RaP2Cre mice, however, these differences were only significant at 12 weeks (Table 1). Independent of age, intraperitoneal GTTs demonstrated normal glucose tolerance in male (Fig. 3A and B) and female (data not shown) IGF-1RaP2Cre and control mice. Intraperitoneal ITTs at 12 and 24 weeks of age in male (Fig. 3C and D) and female mice (data not shown) were indistinguishable between IGF-1RaP2Cre and control mice. Taken together, reducing IGF-1R expression in adipose tissue results in increased somatic growth in the absence of major metabolic alterations.
###end p 39
###begin title 40
###xml 57 63 57 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
IGF-1 serum concentration is markedly increased in IGF-1RaP2Cre mice.
###end title 40
###begin p 41
###xml 14 20 14 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 251 257 251 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 323 324 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 317 324 317 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 466 473 466 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 581 587 581 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 694 700 694 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 719 726 719 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 904 910 904 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1013 1019 1013 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1286 1287 1286 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1280 1287 1280 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 1306 1307 1306 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1300 1307 1300 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 1318 1324 1318 1324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1437 1443 1437 1443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
###xml 1032 1036 <span type="species:ncbi:10090">mice</span>
###xml 1325 1329 <span type="species:ncbi:10090">mice</span>
###xml 1466 1470 <span type="species:ncbi:10090">mice</span>
Because IGF-1RaP2Cre mice exhibited an increased postnatal somatic growth, we next determined circulating plasma IGF-1 concentrations as the major determinant of somatic growth in mammals. IGF-1 serum concentration is significantly increased in IGF-1RaP2Cre mice starting at an age of 12 weeks up to 24 weeks of age (Fig. 4A). In parallel to higher IGF-1 serum concentrations, we found significantly higher serum concentrations of the IGF binding protein (IGFBP)-3 (Fig. 4B). On the other hand, serum concentrations of IGFBP-1 and -2 were not significantly different between IGF-1RaP2Cre and control mice (data not shown). GH and IGF-2 serum concentrations were indistinguishable between IGF-1RaP2Cre and control mice (Table 1), indicating that dysregulation of IGF-1 concentrations is not a result of altered pituitary regulation and thus appears to be primarily regulated in peripheral organs of IGF-1RaP2Cre mice. Therefore, we determined IGF-1 and IGFBP-3 mRNA expression in adipose tissue and liver of IGF-1RaP2Cre and control mice to assess whether increased IGF-1 and IGFBP-3 serum concentrations correlate with increased expression in those organs important for the synthesis of these molecules. We found significantly higher IGF-1 mRNA expression both in adipose tissue (Fig. 4C) and liver (Fig. 4D) of IGF-1RaP2Cre mice. In parallel, there was a trend for increased IGFBP-3 mRNA expression in liver and adipose tissue of IGF-1RaP2Cre compared with control mice (data not shown).
###end p 41
###begin p 42
###xml 72 78 72 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 209 215 209 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 364 371 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>E</italic></xref>
###xml 411 417 411 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF-1</italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
To determine whether increased adipose tissue IGF-1 expression in IGF-1RaP2Cre mice was the result of an altered adipocyte autonomous autocrine regulatory loop, we isolated adipocytes from wild-type and IGF-1RaP2Cre mice. Treatment of control adipocytes with recombinant IGF-1 (100 ng/ml) for 6 h ex vivo caused a significant reduction of its own mRNA expression (Fig. 4E). Conversely, in adipocytes from IGF-1RaP2Cre mice, stimulation with IGF-1 did not inhibit IGF-1 mRNA expression but rather resulted in a paradoxical stimulation of IGF-1 mRNA expression.
###end p 42
###begin title 43
Consequences of IGF-1R knockout on adipose tissue morphology and metabolism.
###end title 43
###begin p 44
###xml 42 48 42 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 84 85 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 78 85 78 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 198 204 198 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 292 298 292 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 370 371 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 465 466 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 471 472 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 459 472 453 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic> and <italic>B</italic></xref>
###xml 565 571 559 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 781 787 775 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 864 865 858 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 858 865 852 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 923 929 917 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 968 969 962 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1018 1024 1012 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1093 1099 1087 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 788 792 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
Adipose tissue mass is increased in IGF-1RaP2Cre mice compared with controls (Fig. 2D). The increased adipose tissue mass was related to both increased number and mean volume of adipocytes in IGF-1RaP2Cre mice (data not shown). Mean adipocyte size (diameter) is significantly higher in IGF-1RaP2Cre (105.4 +/- 12 mum) when compared with control (87.3 +/- 9.3 mum) mice (P < 0.05). These differences are more pronounced in epigonadal than in subcutaneous fat (Fig. 5A and B). We found a 1.4-fold increase in insulin receptor mRNA expression in adipocytes from IGF-1RaP2Cre mice (data not shown). To determine the consequences of IGF-1R knockout on adipocyte glucose transport, basal and insulin-stimulated glucose uptake in isolated adipocytes was studied. In adipocytes from IGF-1RaP2Cre mice, basal glucose uptake is unchanged compared with wild-type mice (Fig. 5C). Insulin stimulated glucose uptake is 2.8-fold in IGF-1RaP2Cre and 2.1-fold in wild-type adipocytes (P < 0.05). Despite larger adipocyte size in IGF-1RaP2Cre mice, we found significantly increased insulin sensitivity in IGF-1RaP2Cre compared with wild-type adipocytes.
###end p 44
###begin title 45
DISCUSSION
###end title 45
###begin p 46
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 400 401 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 441 442 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
IGFs (IGF-1 and -2) lead to many different biological effects in target cells such as hepatocytes, myocytes, and adipocytes (13). IGF-1 action is propagated by the IGF-1R. IGF-1R-deficient mice are severely growth retarded, exhibit multiple growth- and differentiation-dependent abnormalities, and die shortly after birth (3). Disruption of IGF-1R in specific tissues or cell types such osteoblasts (5), skeletal muscle (6), and beta-cells (8) further revealed an essential role of IGF-1R signaling in differentiation and growth.
###end p 46
###begin p 47
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 424 430 424 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 692 697 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLUT4</italic>
###xml 702 718 702 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">insulin receptor</italic>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 819 825 819 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 1269 1271 1269 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 1394 1400 1394 1400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1624 1630 1624 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF-1r</italic>
###xml 1630 1632 1630 1632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/</sup>
###xml 1632 1633 1632 1633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1640 1641 1640 1641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 1642 1644 1642 1644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 1666 1672 1666 1672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1967 1973 1967 1973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1986 1992 1986 1992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 175 180 <span type="species:ncbi:9606">human</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 485 500 <span type="species:ncbi:10090">transgenic mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 1401 1405 <span type="species:ncbi:10090">mice</span>
###xml 1634 1638 <span type="species:ncbi:10090">mice</span>
###xml 1673 1677 <span type="species:ncbi:10090">mice</span>
###xml 1974 1978 <span type="species:ncbi:10090">mice</span>
###xml 1993 1997 <span type="species:ncbi:10090">mice</span>
IGF-1 was shown to be an essential regulator of differentiation in 3T3L1 adipocytes (9). Moreover, IGF-1 stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes in vitro (10). However, the physiological role of the IGF-1R signaling in adipose tissue in vivo has not been systematically studied. We therefore created mice lacking the IGF-1R in adipose tissue (IGF-1RaP2Cre mice). To specifically target adipose tissue, we used transgenic mice that express the Cre recombinase cDNA from the adipose-specific fatty acid binding protein (aP2) promoter/enhancer (14). aP2 Cre mice have been used for adipose-selective inactivation of the GLUT4 and insulin receptor genes (11,15,16). Unexpectedly, deletion of IGF-1R was not restricted to WAT and BAT. In most IGF-1RaP2Cre mice, we found a reduction of IGF-1R protein also in the brain, suggesting transgene expression in neuronal tissue in addition to fat. Although aP2 promoter provides adipocyte-restricted expression postnatally, it was recently shown that aP2 has a wider embryonic expression pattern than previously appreciated (17). Throughout embryonic development, the aP2 Cre transgene was consistently found in different cell types of the nervous system (17). Expression of the aP2 Cre transgene during embryonic development might explain the reduced relative brain mass in IGF-1RaP2Cre mice. We excluded aP2 Cre transgene expression in other tissues, including liver and skeletal muscle, by protein expression analyses. Whole-body expression of the transgene would cause growth retardation as demonstrated in IGF-1r+/- mice (4,18). In contrast, IGF-1RaP2Cre mice have increased somatic growth, further suggesting that tissues other than fat and brain are not affected by the ectopic aP2-Cre transgene expression. However, we have to discuss our data with the caution that reduced IGF-1R expression in the brain may contribute to the phenotype of IGF-1RaP2Cre mice. IGF-1RaP2Cre mice are viable and fertile and do not exhibit growth retardation.
###end p 47
###begin p 48
###xml 26 32 26 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 106 112 106 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 253 259 253 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 496 502 496 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 535 541 535 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 811 813 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 847 849 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 889 895 877 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1092 1094 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 1212 1214 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 637 645 <span type="species:ncbi:9606">patients</span>
###xml 748 756 <span type="species:ncbi:9606">patients</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
###xml 927 932 <span type="species:ncbi:9606">human</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
We demonstrate that IGF-1RaP2Cre mice have increased somatic growth starting at an age of 10 weeks. IGF-1RaP2Cre mice are both longer and heavier than their wild-type littermates. The increased growth is not the result of increased food intake in IGF-1RaP2Cre mice. Interestingly, adipose tissue, liver, and heart exhibit higher relative organ weights than other organs, including kidney, skeletal muscle, and spleen, which are increased in size proportionally to the higher body weight of IGF-1RaP2Cre mice. Increased growth in IGF-1RaP2Cre mice is most likely the result of an approximately20% increased IGF-1 serum concentrations. In patients with acromegaly, elevated circulating IGF-1 levels cause increased adult growth and, at least in some patients, may lead to enlarged organs, including hepatomegaly (19) and acromegalic cardiomyopathy (20). In analogy to the phenotype of IGF-1RaP2Cre mice, transgenic expression of human IGF-1 in mice causes a similar phenotype with 1.3-fold increased weight as a result of selective organomegaly without an apparent increase in skeletal growth (21). Moreover, liver-specific IGF-1 overexpression causes 50% increased serum IGF-I levels and enhanced somatic growth (22).
###end p 48
###begin p 49
###xml 90 96 90 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 641 647 641 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
Because circulating GH and IGF-2 levels are normal, increased IGF-1 serum levels in IGF-1RaP2Cre mice are most likely the result of increased IGF-1 expression both in adipose tissue and liver and not of changes caused by an IGF-1R deficiency in the central nervous system. It is difficult to dissect whether adipose or liver-derived IGF-1 primarily increases circulating IGF-1 levels. Interestingly, we identified a negative feedback mechanism for IGF-1 mRNA expression in adipose tissue. In wild-type adipocytes, IGF-1 suppressed its own mRNA expression ex vivo, whereas this negative feedback was blunted in adipocytes isolated from IGF-1RaP2Cre mice. However, increased IGF-1 expression in liver is more difficult to explain.
###end p 49
###begin p 50
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 1044 1050 1044 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1057 1059 1057 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 476 480 <span type="species:ncbi:10116">rats</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
It is difficult to dissect whether adipose or liver-derived IGF-1 primarily increases circulating IGF-1 levels. Our experimental design does not allow for the distinction between hepatic or adipose tissue-derived IGF-1. It has been shown that IGF-1 and IGF-1R mRNA levels are differentially regulated in different tissues (23). Interestingly, presumably adipose tissue-derived IGF-1 does not inhibit hepatic IGF-1 expression as it was shown in the liver of GH-deficient dwarf rats after IGF-1 treatment (24). Another potential explanation for the absence of a negative feedback of IGF-1 on its own expression in liver might be that hepatocytes only express the IGF-1R in very little amounts (25). Alternatively, circulating IGF-1 could be modulated indirectly by affecting its binding proteins. Increased IGFBP-3 mRNA expression in liver in response to increased circulating IGF-1 from adipose tissue could be a potential mediator. Increase in IGFBP-3 was the best and independent predictor of increased IGF-1 serum concentrations in our IGF-1RaP2Cre mice (27).
###end p 50
###begin p 51
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF-1</italic>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 174 180 174 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 377 383 377 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 426 433 426 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
Moreover, deletion of the IGF-1 gene in liver demonstrated that liver-derived IGF-1 is not crucial for somatic growth (26), suggesting that increased somatic growth in IGF-1RaP2Cre mice is primarily due to increased adipose tissue expression. However, previous data suggest that systemic IGF-1 can feedback on hepatic IGF-1 mRNA expression in the GH-deficient state. Our IGF-1RaP2Cre mice have normal GH serum concentrations (Table 1), suggesting that under normal GH levels, hepatic IGF-1 expression does not depend on the same feedback mechanism. Moreover, we cannot explain why increased IGF-1 levels did not cause decreased GH serum concentrations. Therefore, we cannot exclude that reduction of IGF-1R receptor signaling in individual tissues causes a disruption of physiological feedback mechanisms in other systems or tissues. Adipose tissue-derived signals other than circulating IGF-1, GH, and/or IGF-2 might cause increased circulating IGF-1 levels and increased IGF-1 expression in liver and adipose tissue. Further studies are necessary to characterize these signals.
###end p 51
###begin p 52
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 514 520 514 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 826 832 826 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 952 954 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 1034 1040 1034 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
###xml 857 862 <span type="species:ncbi:9606">human</span>
###xml 874 889 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1041 1045 <span type="species:ncbi:10090">mice</span>
Circulating IGF-1 was shown to reduce IGF-1 mRNA expression in liver, whereas GH increases IGF-1 gene expression (23). In our model with normal GH but increased IGF-1 serum concentrations, one would expect decreased rather than the observed increased hepatic IGF-1 mRNA expression. One hypothesis is that lack of IGF-1R signaling in adipose tissue generates signals that indirectly increase both adipose and hepatic IGF-1 expression. However, GH and IGF-2 receptor expressions were indistinguishable between IGF-1RaP2Cre and control mice in both liver and adipose tissue, suggesting that no liver-specific compensatory mechanism accounts for the unsuppressed IGF-1 mRNA expression in liver. In parallel to increased IGF-1 serum concentrations, circulating IGFBP-3, but not IGFBP-1 and -2, was significantly increased in IGF-1RaP2Cre mice. Overexpression of human IGFBP-3 in transgenic mice results in selective organomegaly, including liver and heart (24), suggesting that increased IGFBP-3 levels contribute to organomegaly in IGF-1RaP2Cre mice.
###end p 52
###begin p 53
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1</italic>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 247 253 247 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 371 377 371 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 571 577 571 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 859 865 859 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 975 981 975 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 1231 1233 1231 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 1381 1383 1381 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 1588 1594 1588 1594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1695 1696 1695 1696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1997 2003 1997 2003 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 2189 2195 2189 2195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
###xml 1104 1108 <span type="species:ncbi:10090">mice</span>
###xml 1118 1121 <span type="species:ncbi:9606">men</span>
###xml 1236 1240 <span type="species:ncbi:10090">Mice</span>
###xml 1317 1321 <span type="species:ncbi:10090">mice</span>
###xml 1402 1406 <span type="species:ncbi:10090">mice</span>
###xml 1842 1846 <span type="species:ncbi:10090">mice</span>
###xml 2004 2008 <span type="species:ncbi:10090">mice</span>
###xml 2196 2200 <span type="species:ncbi:10090">mice</span>
Increased circulating IGF-1 by 50% was shown to improve glucose tolerance in mice with a liver-specific overexpression of the Igf-1 gene (22). Interestingly, we did not observe any improvement of glucose tolerance and insulin sensitivity in IGF-1RaP2Cre mice, suggesting that 20% increased IGF-1 levels are not sufficient to enhance whole-body insulin sensitivity. IGF-1RaP2Cre mice do not exhibit significant metabolic alterations. Interestingly, at the age of 12 weeks, when growth curves diverge, fasting blood glucose concentrations are significantly higher in IGF-1RaP2Cre than in controls. Because glucose tolerance is normal at this age, it is difficult to establish causality for elevated glucose concentrations. Higher adipose tissue mass could contribute to these metabolic alterations. We also found lower adiponectin serum concentrations in IGF-1RaP2Cre mice of both sexes. Lower circulating adiponectin levels further suggest that metabolic alterations in IGF-1RaP2Cre mice at 12 weeks of age are a consequence of increased fat mass. Serum adiponectin negatively correlates with fat mass in mice (16) and men (28). Insulin and IGF-1 are capable of binding to each other's receptor, although with different affinities (29). Mice with a targeted disruption of the insulin receptor in adipose tissue (FIRKO mice) are protected from obesity and its metabolic alterations (16). Moreover, these mice exhibit specific morphological changes in adipose tissue, which could be due to a defect in adipose tissue development. We therefore expected alterations in adipose tissue of IGF-1RaP2Cre, because IGF-1R was shown to be important in the growth and differentiation of adipocytes in vitro (9). Despite similarities in the structure and intracellular signaling between insulin and IGF-1Rs, we did not find a severe metabolic phenotype in mice lacking the IGF-1R in adipose tissue. However, we found significantly increased insulin-stimulated glucose uptake into isolated adipocytes from IGF-1RaP2Cre mice, suggesting increased glucose uptake and subsequent increase in lipogenesis as primary causes leading to increased lipid load per adipocyte and adipose tissue hypertrophy in IGF-1RaP2Cre mice.
###end p 53
###begin p 54
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
This further suggests that insulin receptor signaling is more important for fuel metabolism, whereas IGF-1R mediates growth, and that one receptor cannot functionally compensate for the other receptor's absence (13).
###end p 54
###begin p 55
###xml 245 251 245 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 745 747 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 913 929 909 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">insulin receptor</italic>
###xml 973 979 969 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1196 1202 1192 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 1424 1426 1420 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 1530 1532 1526 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 1818 1824 1814 1820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
###xml 1203 1207 <span type="species:ncbi:10090">mice</span>
###xml 1294 1298 <span type="species:ncbi:10090">mice</span>
Our data further show that IGF-1R signaling in adipocytes is not crucial for the growth, development, or differentiation of adipose tissue in vivo. Unexpectedly, both the number and the size of adipocytes is increased in adipose tissue of IGF-1RaP2Cre mice, either suggesting that intact IGF-1R is not necessary for adipose tissue development or that other mechanisms exist in vivo, which can compensate for the disruption of IGF-1R. In accordance with our results, it was recently shown that most IGF receptor-deficient adipocyte cell lines were capable of normal differentiation (13). Moreover, important markers of adipogenesis, including peroxisome proliferator-activated receptor-gamma and GLUT4, were expressed despite the lack of IGF-1R (13). One potential mechanism could be that insulin receptor mediates the IGF-1 effects on growth and differentiation in vivo. This hypothesis is supported by increased insulin receptor gene expression in adipose tissue of IGF-1RaP2Cre mice. However, in vitro there was no compensation of insulin receptor when the IGF-1R was absent. Therefore, it appears that IGF-1R is not crucial for adipose tissue development. Interestingly, adipocytes from IGF-1RaP2Cre mice were more sensitive to insulin-stimulated glucose uptake than adipocytes from control mice. Our findings are in accordance with previously reported increased insulin sensitivity in IGF-1R-deficient brown adipocytes (30). Moreover, downregulation of IGF-1R in breast cancer cells was shown to increase insulin sensitivity (31). Diminished IGF-1R/insulin receptor hybrid receptor formation resulting in enhanced holo-insulin receptor formation could contribute to increased insulin sensitivity in IGF-1R-deficient adipocytes. In addition, increased insulin receptor number might enhance insulin effects on IGF-1RaP2Cre adipocytes.
###end p 55
###begin p 56
In conclusion, IGF-1R signaling in adipocytes is not crucial for the development and differentiation of adipose tissue in vivo but seems to participate in the regulation of IGF-1 serum concentration.
###end p 56
###begin p 57
M.B. has received Deutsche Forschungsgemeinschaft Grant BL 580/3-1, Clinical Research group Atherobesity KFO 152 Project BL 833/1-1, and Project B24 from the Interdisciplinary Center of Clinical Research Leipzig at the Faculty of Medicine of the University of Leipzig.
###end p 57
###begin title 58
REFERENCES
###end title 58
###begin p 59
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 315 321 315 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">igf-1r</italic>
###xml 328 331 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 394 395 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 536 542 536 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 597 603 597 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 610 616 610 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 709 715 709 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 718 719 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 890 896 884 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 375 382 <span type="species:ncbi:301928">ellipse</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
Targeting strategy, assessment of IGF-1R recombination, and IGF-1R expression. A: Schematic representation of the loxP-flanked IGF-1R allele before and after recombination (Cre-expression). The knockout allele is shown below the floxed allele, indicating the deletion of exon 3 in the event of recombination of the igf-1r gene. BamHI, restriction sites; triangle, loxP site; ellipse, FRT site. B: Results from PCR analysis of DNA prepared from isolated adipocytes. DNA from isolated adipocytes of wild-type mice produced a 300-bp band (lane 1), whereas a single 380-bp band was detected for IGF-1RaP2Cre mice (lane 3). Heterozygous expression of the transgene was detected by both a 300-bp and a 380-bp band (lane 2). C: Western blot analysis for IGF-1R beta-subunit and beta-actin as loading control of WAT, liver, brain, and skeletal muscle of two representative wild-type (WT) and IGF-1RaP2Cre mice.
###end p 59
###begin p 60
###xml 26 32 26 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 58 64 58 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 151 157 151 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 251 252 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 352 358 352 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 417 418 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 419 420 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 481 487 481 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 506 507 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 542 548 542 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 601 602 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 622 623 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 649 650 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 687 693 687 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 808 809 808 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 847 853 847 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
Growth phenotype of IGF-1RaP2Cre mice and controls. IGF-1RaP2Cre mice show identical growth until an age of 10 weeks. Thereafter, body weight of IGF-1RaP2Cre mice is significantly increased both in males (A) and females (B) until an age of 32 weeks. *P < 0.05, **P < 0.01, ***P < 0.001. C: Body length (naso-anal length) is markedly increased in IGF-1RaP2Cre mice at an age of 24 weeks (n = 10 per genotype and sex). D-F: Organ weights relative to body weight in 24-week-old IGF-1RaP2Cre and control mice (n = 10 per genotype and sex). IGF-1RaP2Cre mice exhibit increased relative epigonadal fat pad (D) and liver weight (E). Relative brain weight (F) was significantly reduced in IGF-1RaP2Cre mice, possibly as a consequence of heterozygous transgene (aP2) expression in brain, whereas relative BAT weight (G) was indistinguishable between IGF-1RaP2Cre and control mice.
###end p 60
###begin p 61
###xml 6 12 6 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 183 189 183 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 264 265 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 270 271 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 305 306 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 325 326 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 363 369 361 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
IGF-1RaP2Cre mice have normal glucose tolerance and insulin sensitivity. A and B: GTTs performed on 12-h-fasted 12-week old (A) and 24-week-old (B) male wild-type (control) and IGF-1RaP2Cre mice. Results are expressed as means +/- SE from 10 animals per genotype. C and D: ITTs on random fed 12-week-old (C) and 24-week-old (D) male wild-type (control) and IGF-1RaP2Cre mice. Results are expressed as means +/- SE from 10 animals per genotype.
###end p 61
###begin p 62
###xml 100 106 100 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 201 207 201 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 327 333 327 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 365 366 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 375 376 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 403 404 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 409 410 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 453 454 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 484 485 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 494 495 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 529 530 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 574 575 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 588 589 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 592 593 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 654 655 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 668 669 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 672 673 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 743 744 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 840 841 840 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 896 901 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf-1</italic>
###xml 968 973 966 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">36B4.</italic>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 825 831 <span type="species:ncbi:10090">murine</span>
IGF-1, IGFBP-3 serum concentrations, and IGF-1 mRNA expression in adipose tissue and liver of IGF-1RaP2Cre and wild-type (control) mice. A: IGF-1 serum concentrations are significantly higher in IGF-1RaP2Cre compared with wild-type mice. **P < 0.01, n = 10 per genotype and sex. B: Higher IGFBP-3 serum concentrations in IGF-1RaP2Cre compared with wild-type mice. *P < 0.05, n = 5 per genotype and sex. C and D: IGF-1 mRNA expression in adipose tissue (C) and liver (D). *P < 0.05, **P < 0.01; n = 10 per genotype and sex. E and F: IGF-2R mRNA expression in adipose tissue (E) and liver (F). G and H: GH receptor (GHR) mRNA expression in adipose tissue (G) and liver (H). I: IGF-1 mRNA expression in isolated adipocytes from 24-week-old male (n = 5 per genotype) after 6 h of incubation with or without 100 ng/ml recombinant murine IGF-1. *P < 0.05. Values are means +/- SE. AU, arbitrary units. Igf-1 mRNA expression was calculated relative to the mRNA expression of 36B4.
###end p 62
###begin p 63
###xml 112 118 112 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 249 255 249 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 399 405 399 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 530 536 530 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 647 653 647 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 660 661 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 740 746 740 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 899 900 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
Hypertrophy of adipocytes in WAT and normal insulin stimulated glucose uptake into isolated adipocytes of IGF-1RaP2Cre mice. A: Hematoxylin-eosin staining of WAT (epigonadal and subcutaneous) and BAT sections from random-fed, 24-week-old male IGF-1RaP2Cre and wild-type (control) mice. Initial magnification, x10. B: Distribution curves of epigonadal and subcutaneous isolated adipocytes from IGF-1RaP2Cre and wild-type mice (pooled from five mice per genotype). Subcutaneous size distribution was indistinguishable between IGF-1RaP2Cre and control mice, whereas both mean and maximum epigonadal adipocyte size is significantly increased in IGF-1RaP2Cre mice. C: Relative glucose uptake into isolated adipocytes from 24-week-old male IGF-1RaP2Cre and wild-type (control) mice. Insulin stimulation was performed for 30 min at 100 nmol/l. Data represent means +/- SE of five independent experiments. *P < 0.05.
###end p 63
###begin p 64
###xml 66 72 66 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">aP2Cre</sup>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Metabolic parameters in 12- and 24-week-old male and female IGF-1RaP2Cre and control mice
###end p 64
###begin p 65
Significant differences from control:
###end p 65
###begin p 66
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.05,
###end p 66
###begin p 67
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.01,
###end p 67
###begin p 68
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
P < 0.001.
###end p 68

